Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer

Neoadjuvant chemotherapy is given before surgery to patients with primarily unresectable, advanced-stage cancers to render the tumor resectable, and to facilitate breast conservation. Previously, we have reported a prospective phase II trial for women with stage IIA-B/IIIA-B-C breast cancer with imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Ping-Ching, Kadlubar, Susan A., Siegel, Eric R., Rogers, Lora J., Todorova, Valentina K., Su, L. Joseph, Makhoul, Issam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162481/
https://www.ncbi.nlm.nih.gov/pubmed/32298288
http://dx.doi.org/10.1371/journal.pone.0230248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162481/
https://www.ncbi.nlm.nih.gov/pubmed/32298288
http://dx.doi.org/10.1371/journal.pone.0230248

Ejemplares similares